Opportunity ID: 51323

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-10-095
Funding Opportunity Title: Pre-Application for the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction (X02)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 26, 2010
Last Updated Date:
Original Closing Date for Applications: Mar 22, 2010
Current Closing Date for Applications: Mar 22, 2010
Archive Date: Apr 22, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
County governments
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
City or township governments
Native American tribal governments (Federally recognized)
State governments
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Special district governments
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The purpose of this funding opportunity announcement (FOA) is to encourage pre-applications for The NIDA Translational Avant-Garde Award. The NIDA Translational Avant-Garde Award is designed to support dedicated and talented basic and/or clinical researchers with the vision, drive and expertise necessary to translate research discoveries into medications for the treatment of diseases of addiction. Through this FOA, the National Institute on Drug Abuse (NIDA) is committed to making significant advances in the development of safe and efficacious products for the treatment of disorders stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use or abuse.
Mechanism of Support. This announcement will utilize the X02 mechanism for submission and consideration of pre-applications. The X02 pre-application is a first step in applying for a Translational Avant-Garde Award.
Funds Available and Anticipated Number of Awards. No awards will be made under this announcement. Through the associated FOA (RFA-DA-10-013), NIDA expects to commit approximately $ 2 million per year for 5 years to fund 2-3 awards.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-10-095.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.279 ADOBE-FORMS-B Use for submissions intended for due dates of January 25, 2010 and beyond PKG00016039 Feb 22, 2010 Mar 22, 2010 View

Package 1

Mandatory forms

51323 RR_SF424_1_2-1.2.pdf

51323 PerformanceSite_1_3-1.3.pdf

51323 RR_OtherProjectInfo_1_2-1.2.pdf

51323 RR_KeyPersonExpanded_1_2-1.2.pdf

51323 PHS398_CoverPageSupplement_1_4-1.4.pdf

51323 PHS398_ResearchPlan_1_3-1.3.pdf

Optional forms

51323 PHS_CoverLetter_1_2-1.2.pdf

2025-07-11T04:18:26-05:00

Share This Post, Choose Your Platform!

About the Author: